Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Agenus 3.02 0.04 1.34% -10.91%
Amgen 201.17 0.37 0.18% -11.34%
Anika Therapeutics 39.68 1.15 2.98% 8.39%
Arrowhead Research 69.69 2.69 4.01% 8.92%
AstraZeneca 8,198.00 -33.00 -0.40% 3.02%
Bluebird Bio 10.63 0.58 5.77% -77.37%
Bristol-Myers Squibb 55.41 0.46 0.84% -10.31%
ChemoCentryx 37.06 1.58 4.45% -33.89%
Dicerna Pharmaceuticals 38.12 0.02 0.05% 54.33%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
Gilead Sciences 69.67 0.74 1.07% 14.48%
GlaxoSmithKline 1,535.20 1.20 0.08% 10.76%
Heron Therapeutics 9.36 0.28 3.08% -45.30%
Immunogen 7.16 0.39 5.76% 23.13%
Incyte Corp 66.63 1.67 2.57% -19.63%
Karyopharm Therapeutics 7.28 0.59 8.82% -56.20%
Ligand Pharmaceuticals 156.92 2.70 1.75% 83.79%
MacroGenics 17.33 0.72 4.33% -23.28%
MannKind 4.42 0.10 2.31% 55.09%
Merck & Co 73.89 -0.55 -0.74% -9.28%
Novartis 74.13 0.33 0.45% -8.71%
Peregrine Pharmaceuticals 31.50 0.95 3.11% 184.81%
Rigel Pharmaceuticals 2.61 0.01 0.38% -13.29%
Roche Holding 366.90 3.45 0.95% 21.39%
Sangamo BioSciences 8.45 0.44 5.49% -14.30%
Thermo Fisher Scientific 627.58 1.43 0.23% 31.51%
Veracyte 39.22 1.30 3.43% -29.84%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Xencor 36.73 1.05 2.94% -5.34%
Intrexon 3.99 0.14 3.64% -52.92%
Ziopharm Oncology 1.32 0.05 3.94% -52.00%

Indexes Price Day Year
US2000 2206 58.91 2.74% 19.35%

Intrexon
Precigen, Inc. (Precigen) is a synthetic biology company that focuses on its discovery and clinical-stage activities to advance gene and cellular therapies to target immuno-oncology, autoimmune disorders, and infectious diseases. The Company is offering a class of microbe-based biopharmaceuticals that enable the expression and local delivery of disease-modifying therapeutics. Precigen is using precision technology to target intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. The Company also focused on studying life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications. The Company’s subsidiaries include PGEN Therapeutics, Inc., Precigen ActoBio, Inc., Exemplar Genetics, LLC and Trans Ova Genetics, L.C.